Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Supriya Lifescience Ltd Q1FY24; 16% rise in Profits
Categories
pharmaceuticals
Sun Pharmaceuticals Industries Ltd Q1FY24; 4% fall in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Strides Pharma Science Ltd Q1FY24; 1% fall in Revenue
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Ajanta Pharma Ltd Q1FY24; 19% rise in Profits.
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported
Cipla Ltd Q1FY24; 41% rise in Profits.
Cipla is engaged in the Business of Pharmaceuticals. Financial Results: Cipla Ltd reported Revenues for Q1FY24 of ₹6,329.00 Crores up from ₹5,375.00
Dr Reddy’s Laboratories Ltd Q1FY24; 18% rise in Profits.
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients
Glaxosmithkline Pharmaceuticals Ltd Q1 FY24; 11% rise in Profits
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results:
Indoco Remedies Ltd Q1 FY24; 38% fall in Profits
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company
Aarti Drugs Ltd Q1FY24; 54% rise in Profits.
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Glenmark Life Sciences Ltd Q1 FY24; 24% rise in Profits
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Jubilant Pharmova Ltd Q1 FY24; 87% fall in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Unichem Laboratories Ltd Q1FY24; 37% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues
Biocon Ltd.: Driving Growth in Pharmaceutical Industry.
Stock Data: TickerNSE: BIOCONExchangeNSEIndustryPHARMACEUTICALS Price Performance: Last 5 Days+1.43%YTD-7.18%Last 12 Months-22.16%As on 16-06-2023 Company Description: Biocon is India's premier biotechnology company. It
Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%
Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the
Alphagraph | Aurobindo Pharma Ltd (NSE: AUROPHARMA): Q4FY23 Results Out; Total Income rises 13% YoY.
Aurobindo Pharma is a leading pharmaceutical company primarily involved in the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and
Alphagraph | Brooks Laboratories Ltd (NSE: BROOKS): Q4FY23 Results Out; Total Income fell 56% YoY.
Brooks Laboratories Ltd is a pharmaceutical manufacturing company that primarily operates on a contract basis. The company specializes in the production of
Earnings Summary Of FDC Limited For Q4 FY23
FDC Limited is a renowned Indian pharmaceutical company that has been in operation for over 85 years. Founded in 1936, the company
AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai Patel -- Executive Chairman
Earnings | Albert David Ltd (NSE: ALBERTDAVD): Q4FY23 Results Out; Total Income rises 9% YoY.
Albert David Ltd is a pharmaceutical company involved in both manufacturing and trading activities. The company focuses on the production of Pharmaceutical
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and Chief Financial